IDEXX Laboratories Inc.

United States of America Country flag United States of America
Sector: Medical Supplies
Ticker: IDXX
Factsheet Factsheet

Market multiple valuation of IDEXX Laboratories Inc. ( IDXX | USA)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is significantly higher than the median of its peer group: around 25.00. The company valuation of IDEXX Laboratories Inc. according to these metrics is way above the market valuation of its peer group.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is significantly higher than the average of its sector (Medical Supplies): 15.87. The company valuation of IDEXX Laboratories Inc. according to these metrics is way above the market valuation of its sector.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is lower than its historical 5-year average: 53.7. The (current) company valuation of IDEXX Laboratories Inc. is therefore below its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2024P/E NTM
IDEXX Laboratories Inc.Free trialFree trialFree trial
International PeersFree trialFree trialFree trial
Medical Supplies12.2316.4015.87
NASDAQ 10026.4223.6722.94
United States of America6.4611.8211.78
More...
Beta (Ref: NASDAQ 100)
Levered betaUnlevered beta
1-Year1.181.16
2-Year1.111.10
3-Year1.071.06
More...
Stock Perf excl. Dividends (in USD)
IDXXNASDAQ 100Rel. Perf.
Year-to-Date-10.3%7.0%-17.3%
1-Week-4.2%-0.6%-3.6%
1-Month-9.0%-1.2%-7.8%
1-Year5.7%40.1%-34.4%
3-Year-1.7%30.3%-32.0%
5-Year120.9%136.0%-15.1%
More...
International Peers - IDEXX Laboratories Inc.
Company NameCtryMarket
Cap.
last (mUSD)
IDEXX Laboratories Inc.USA41 264
International Peers Median1.46
Abbott LaboratoriesUSA189 421
Thermo Fisher Scientifi...USA218 389
Charles River Laborator...USA12 432
Bio-Rad Laboratories In...USA8 699
Lepu Medical Technology...CHN3 494
GPRV Analysis
IDEXX Laboratories I...
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
More...
Quotes Chart

1-Year Rebased Stock Chart

  • IDEXX Laboratories Inc.
  • NASDAQ 100
More...

Did you know ?

Multiples charts provide an effective way to quickly analyze a company's valuation over a period of time, and compare it against the valuation of another company, a personal list, or a market index.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).